drugset / Trial / NCT04764383
Histaminergic Basis of Fatigue in Multiple Sclerosis
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this research study is to identify a way to improve the feeling of exhaustion that patients might experience because of Multiple Sclerosis (MS).
Timeline
- Start
- 2022-01-01
- Primary completion
- 2022-10-30
- Completion
- 2022-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HISTIDINE | Small molecule | 1000 mg | Oral |
| Subject | Lodosyn | Unknown | 50 mg | Oral |